Abstract
Successful cancer gene therapy requires a vector that systemically and specifically targets tumor cells throughout the body. Although several vectors have been developed to express cytotoxic genes via tumor-specific promoters or to seclectively replicate in tumor cells, most are taken up and expressed by just a few targeted tumor cells. By contrast, we show here that blood-borne Sindbis viral vectors systemically and specifically infect tumor cells. A single intraperitoneal treatment allows the vectors to target most tumor cells, as demonstrated by immunohistochemistry, without infecting normal cells. Further, Sindbis infection is sufficient to induce complete tumor regression. We demonstrate systemic vector targeting of tumors growing subcutaneously, intrapancreatically, intraperitoneally and in the lungs. The vectors can also target syngeneic and spontaneous tumors in immune-competent mice. We document the anti-tumor specificity of a vector that systemically targets and eradicates tumor cells throughout the body without adverse effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akporiaye, E.T. & Hersh, E. Clinical aspects of intratumoral gene therapy. Curr. Opin. Mol. Ther. 1, 443–453 (1999).
Green, N.K. & Seymour, L.W. Adenoviral vectors: systemic delivery and tumor targeting. Cancer Gene Ther. 9, 1036–1042 (2002).
Biederer, C., Ries, S., Brandts, C.H. & McCormick, F. Replication-selective viruses for cancer therapy. J. Mol. Med. 80, 163–175 (2002).
Bredenbeek, P.J., Frolov, I., Rice, C.M. & Schlesinger, S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67, 6439–6446 (1993).
Strauss, J.H. & Strauss, E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58, 491–562 (1994).
Ryman, K.D., Klimstra, W.B., Nguyen, K.B., Biron, C.A. & Johnston, R.E. α/β interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74, 3366–3378 (2000).
Cook, S.H. & Griffin, D.E. Luciferase imaging of a neurotropic viral infection in intact animals. J. Virol. 77, 5333–5338 (2003).
Tseng, J.C. et al. In vivo antitumor activity of Sindbis viral vectors. J. Natl. Cancer Inst. 94, 1790–1802 (2002).
Wang, K.S., Kuhn, R.J., Strauss, E.G., Ou, S. & Strauss, J.H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66, 4992–5001 (1992).
Strauss, J.H., Wang, K.S., Schmaljohn, A.L., Kuhn, R.J. & Strauss, E.G. Host-cell receptors for Sindbis virus. Arch. Virol. Suppl. 9, 473–484 (1994).
Martignone, S. et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J. Natl. Cancer Inst. 85, 398–402 (1993).
Sanjuan, X. et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J. Pathol. 179, 376–380 (1996).
de Manzoni, G. et al. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn. J. Clin. Oncol. 28, 534–537 (1998).
Taraboletti, G., Belotti, D., Giavazzi, R., Sobel, M.E. & Castronovo, V. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J. Natl. Cancer Inst. 85, 235–240 (1993).
Ozaki, I. et al. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 43, 837–842 (1998).
van den Brule, F.A. et al. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur. J. Cancer 32A, 1598–1602 (1996).
van den Brule, F.A. et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur. J. Cancer 30A, 1096–1099 (1994).
Liebman, J.M., Burbelo, P.D., Yamada, Y., Fridman, R. & Kleinman, H.K. Altered expression of basement-membrane components and collagenases in ascitic xenografts of OVCAR-3 ovarian cancer cells. Int. J. Cancer 55, 102–109 (1993).
Cioce, V. et al. Increased expression of the laminin receptor in human colon cancer. J. Natl. Cancer Inst. 83, 29–36 (1991).
Menard, S., Tagliabue, E. & Colnaghi, M.I. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast. Cancer. Res. Treat. 52, 137–145 (1998).
Viacava, P. et al. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. J. Pathol. 182, 36–44 (1997).
Liotta, L.A. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46, 1–7 (1986).
Aznavoorian, S., Murphy, A.N., Stetler-Stevenson, W.G. & Liotta, L.A. Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368–1383 (1993).
Liotta, L.A., Rao, N.C., Barsky, S.H. & Bryant, G. The laminin receptor and basement membrane dissolution: role in tumour metastasis. Ciba Found. Symp. 108, 146–162 (1984).
Levine, B. et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361, 739–742 (1993).
Jan, J.T., Chatterjee, S. & Griffin, D.E. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74, 6425–6432 (2000).
Jan, J.T. & Griffin, D.E. Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J. Virol. 73, 10296–10302 (1999).
Balachandran, S. et al. α/β interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74, 1513–1523 (2000).
Frolov, I. & Schlesinger, S. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J. Virol. 68, 1721–1727 (1994).
Frolova, E.I. et al. Roles of nonstructural protein nsP2 and α/β interferons in determining the outcome of Sindbis virus infection. J. Virol. 76, 11254–11264 (2002).
Olivo, P.D., Frolov, I. & Schlesinger, S. A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses. Virology 198, 381–384 (1994).
Putzer, B.M., Rodicker, F., Hitt, M.M., Stiewe, T. & Esche, H. Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model. Mol. Ther. 5, 405–412 (2002).
Liotta, L.A. et al. Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. Exp. Cell Res. 156, 117–126 (1985).
Barsky, S.H., Rao, C.N., Hyams, D. & Liotta, L.A. Characterization of a laminin receptor from human breast carcinoma tissue. Breast Cancer Res. Treat. 4, 181–188 (1984).
Terranova, V.P., Rao, C.N., Kalebic, T., Margulies, I.M. & Liotta, L.A. Laminin receptor on human breast carcinoma cells. Proc. Natl. Acad. Sci. USA 80, 444–448 (1983).
Byrnes, A.P. & Griffin, D.E. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72, 7349–7356 (1998).
Leucht, C. et al. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4, 290–295 (2003).
Gauczynski, S. et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863–5875 (2001).
Yaghoubi, S.S. et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 8, 1072–1080 (2001).
Adams, J.Y. et al. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med. 8, 891–897 (2002).
Polo, J.M. et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. USA 96, 4598–4603 (1999).
Antonio Chiocca, E. Oncolytic viruses. Nat. Rev. Cancer 2, 938–950 (2002).
Acknowledgements
We thank Elizabeth W. Newcomb, Christine Pampeno and Colby Collier for critical reading of this manuscript and helpful discussions. This study was supported by US Public Health Service grants CA22247 and CA68498 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, by U.S. Army grant 0C000111 and by a generous gift from the Karan-Weiss Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Tseng, JC., Levin, B., Hurtado, A. et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22, 70–77 (2004). https://doi.org/10.1038/nbt917
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt917
This article is cited by
-
Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain
Pediatric Surgery International (2015)
-
Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity
Molecular Therapy (2014)
-
Tumor-Specific Targeting With Modified Sindbis Viral Vectors: Evaluation with Optical Imaging and Positron Emission Tomography In Vivo
Molecular Imaging and Biology (2013)
-
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Journal of Translational Medicine (2012)
-
A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors
Gene Therapy (2012)